marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-11-2024
NGM Biopharmaceuticals Financial Ratios 2011-2024 | NGM
Annual Financial Ratios NGM Biopharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.9 | -2.3 | -11.3 | -20.2 | -19.4 | - | - | - | - | - | - | - | - |
P/S |
28.8 | 6.8 | 17.5 | 23.7 | 8.0 | - | - | - | - | - | - | - | - |
EPS |
-1.7 | -2.0 | -1.6 | -1.5 | -0.8 | -0.1 | -2.4 | - | - | - | - | - | - |
EV (Enterprise Value) |
91.5 M | 349 M | 1.28 B | 1.97 B | 635 M | 36 K | 342 M | 392 M | - | - | - | - | - |
EBITDA per Share |
-1.81 | -2.03 | -1.49 | -1.42 | -0.83 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-10.7 | -16.8 | -14.0 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.23 | 0.0 | - | - | - | - | - | - | - | - | ||
P/B |
0.9 | 1.4 | 4.1 | 7.4 | 2.5 | - | - | - | - | - | - | - | - |
P/CF |
-1.0 | -2.6 | -18.6 | -24.8 | -18.6 | - | - | - | - | - | - | - | - |
ROE % |
-95.79 | -62.67 | -35.85 | -36.60 | -12.94 | - | - | - | - | - | - | - | - |
ROA % |
-84.31 | -52.92 | -29.91 | -31.15 | -11.25 | - | - | - | - | - | - | - | - |
ROCE % |
-101.90 | -64.05 | -35.96 | -37.08 | -14.48 | - | - | - | - | - | - | - | - |
Current Ratio |
8.3 | 6.4 | 6.0 | 6.7 | 8.9 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 18.4 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios NGM Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.35 | -0.46 | -0.58 | - | -0.59 | -0.59 | -0.42 | - | -0.37 | -0.48 | -0.36 | - | -0.43 | -0.38 | -0.28 | -0.24 | -0.17 | -0.13 | -1.21 | - | -1.15 | -0.52 | -0.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.37 | -0.48 | -0.6 | - | -0.59 | -0.58 | -0.4 | - | -0.36 | -0.45 | -0.35 | - | -0.41 | -0.35 | -0.28 | -0.26 | -0.17 | -0.13 | -1.08 | 1.88 | -1.01 | -0.4 | -0.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-74.97 | -74.54 | -70.56 | -42.89 | -51.04 | -42.66 | -36.57 | -24.88 | -35.51 | -37.99 | -37.30 | -26.60 | -31.42 | -24.09 | -17.27 | -12.94 | -21.21 | -10.96 | -5.69 | 0.46 | 13.55 | 6.60 | 3.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-64.81 | -63.90 | -55.57 | -32.11 | -39.05 | -22.90 | -31.58 | -21.80 | -30.84 | -32.95 | -32.06 | -22.64 | -26.83 | -20.65 | -14.89 | -11.25 | -1.30 | -1.49 | -0.77 | -0.20 | -5.96 | -2.90 | -1.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-79.01 | -77.63 | -72.63 | -43.48 | -51.67 | -42.97 | -36.67 | -24.98 | -35.67 | -38.18 | -37.48 | -27.20 | -32.43 | -25.66 | -19.48 | -14.92 | -21.76 | -10.00 | -3.20 | 3.99 | 16.05 | 8.23 | 4.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
8.6 | 7.8 | 6.8 | 6.4 | 6.7 | - | 7.4 | 6.0 | 6.7 | 8.5 | 9.7 | 6.7 | 6.7 | 6.7 | 6.7 | 7.7 | 7.7 | 7.7 | 7.7 | 4.1 | 4.1 | 4.1 | 4.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency